May 19, 2020 – We are proud to share that Castle Creek Biosciences, a portfolio company of Paragon Biosciences, is featured in Philadelphia Magazine as a company on the cutting edge of cell and gene therapy innovation!

The special feature was published as “Yes, Science Can Save Us” in the May 2020 print issue of Philadelphia Magazine and is now available online here. An in-depth interview with Castle Creek Biosciences’ CEO John Maslowski previously appeared in Philadelphia Magazine’s “NextUp,” a weekly feature that highlights the local leaders, organizations and research shaping the Greater Philadelphia region’s life sciences ecosystem.

“We identified an important need and potential breakthrough therapy and are applying long-term capital, expertise, and strong support to deliver for patients and their families. As founder of Castle Creek Biosciences, I’m proud that they have taken this exciting next step in our shared mission of solving the most complex human and societal challenges through life science innovation.” – Jeff Aronin, Chairman and CEO of Paragon

Congratulations to Harmony Biosciences for being ranked 8th on the Fortune Best Healthcare and Biopharma workplaces list
Horizon Technology Finance and Emalex Biosciences Announce $15 Million Venture Loan Facility